Heparin Sodium 2 — Class I drug recall D-1550-2020
Terminated recall by SCA Pharmaceuticals, reported 2020-09-02, distributed nationwide. Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as pre
| Recall number | D-1550-2020 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | SCA Pharmaceuticals, Windsor, CT, United States |
| Recall initiated | 2020-07-29 |
| Classified | 2020-08-27 |
| Reported by FDA | 2020-09-02 |
| Terminated | 2021-05-21 |
| Distributed | Nationwide (US) |
| Quantity | 1,097 containers |
| Reason classes | undeclared allergen, labeling |
| NDC | 70004-0655-44 |
| Lot numbers | 1220019269, 1220019278, 1220019386 |
| Expiration dates | 2020-08-21, 2020-08-25 |
Product
Heparin Sodium 2,500 units in 0.9% Sodium Chloride 500 mL, Single Dose Container, Rx Only Injection for Intravenous Use (5 units/mL), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC#: 70004-0655-44, Bar Code 70004065544.
Reason for recall
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1550-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.